KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tenet Healthcare (THC) Gross Profit (2016 - 2025)

Historic Gross Profit for Tenet Healthcare (THC) over the last 17 years, with Q4 2025 value amounting to $4.3 billion.

  • Tenet Healthcare's Gross Profit rose 846.27% to $4.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $16.8 billion, marking a year-over-year increase of 373.23%. This contributed to the annual value of $16.8 billion for FY2025, which is 373.23% up from last year.
  • Latest data reveals that Tenet Healthcare reported Gross Profit of $4.3 billion as of Q4 2025, which was up 846.27% from $4.2 billion recorded in Q3 2025.
  • In the past 5 years, Tenet Healthcare's Gross Profit registered a high of $4.3 billion during Q4 2025, and its lowest value of $3.6 billion during Q2 2022.
  • For the 5-year period, Tenet Healthcare's Gross Profit averaged around $4.0 billion, with its median value being $4.0 billion (2022).
  • As far as peak fluctuations go, Tenet Healthcare's Gross Profit soared by 4634.15% in 2021, and later plummeted by 687.18% in 2022.
  • Over the past 5 years, Tenet Healthcare's Gross Profit (Quarter) stood at $3.8 billion in 2021, then rose by 3.42% to $4.0 billion in 2022, then increased by 6.09% to $4.2 billion in 2023, then fell by 4.88% to $4.0 billion in 2024, then increased by 8.46% to $4.3 billion in 2025.
  • Its Gross Profit stands at $4.3 billion for Q4 2025, versus $4.2 billion for Q3 2025 and $4.2 billion for Q2 2025.